Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 10,000 shares at $24.10 ($241K) on 2017-12-19, disclosed to the SEC on 2017-12-20.
Open-market sale of $241k BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.10 | 2,000 | $48K | 20.0% |
| 2 | $24.10 | 8,000 | $193K | 80.0% |
| Total | $24.10 avg | 10,000 | $241K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | BUY | 2019-06-28 | $106K | — | Filing → |